Hyperthermia enhances the sensitivity of pancreatic cancer SW1990 cells to gemcitabine through ROS/JNK signaling
/in Hyperthermia, International Publications, Pancreatic Cancer /von 2018-09-18 / Oncol Lett 2018 Nov;16(5):6742-6748Immunogenic Effect of Hyperthermia on Enhancing Radiotherapeutic Efficacy
/in Hyperthermia, International Publications /von 2018-09-17 / Int J Mol Sci 2018 Sep;19(9)Complete Clinical Remission of Stage IV Triple-Negative Breast Cancer Lung Metastasis Administering Low-Dose Immune Checkpoint Blockade in Combination With Hyperthermia and Interleukin-2
/in Breast Cancer, Checkpoint-Inhibitors, Hyperthermia, International Publications /von 2018-09-07 / Integr Cancer Ther 2018 12;17(4):1297-1303Enhancement of Radiation Effectiveness in Cervical Cancer Cells by Combining Ionizing Radiation with Hyperthermia and Molecular Targeting Agents
/in Cervical Cancer, Hyperthermia, International Publications /von 2018-08-16 / Int J Mol Sci 2018 Aug;19(8)Chemotherapy Sensitizes Therapy-Resistant Cells to Mild Hyperthermia by Suppressing Heat Shock Protein 27 Expression in Triple-Negative Breast Cancer
/in Breast Cancer, Hyperthermia, International Publications /von 2018-06-19 / Clin. Cancer Res. 2018 Oct;24(19):4900-4912Hyperthermia in cervical cancer – current status
/in Cervical Cancer, Hyperthermia, International Publications /von 2018-06-15 / Rep Pract Oncol Radiother 2018 Nov-Dec;23(6):595-603New physical approaches to treat cancer stem cells: a review
/in Hyperthermia, International Publications /von 2018-06-04 / Clin Transl Oncol 2018 Dec;20(12):1502-1521The Efficacy of Radiofrequency Hyperthermia Combined with Chemotherapy in the Treatment of Advanced Ovarian Cancer
/in Hyperthermia, International Publications, Ovarian Cancer /von 2018-06-01 / Open Med (Wars) 2018;13:83-89Effect of Neoadjuvant Chemotherapy Plus Regional Hyperthermia on Long-term Outcomes Among Patients With Localized High-Risk Soft Tissue Sarcoma: The EORTC 62961-ESHO 95 Randomized Clinical Trial
/in Hyperthermia, International Publications, Soft Tissue Sarcoma /von 2018-04-01 / JAMA Oncol 2018 Apr;4(4):483-492
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de